Patents by Inventor Kyung Sik Song

Kyung Sik Song has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11426731
    Abstract: A cartridge for digital real-time Polymerase chain reaction (PCR) includes a microfluidic chamber, a well array, a CMOS photo sensor array and a PCB. The microfluidic chamber includes an inlet formed for injection of a liquid sample, the microfluidic chamber being capable of injection molding. The well array includes a plurality of microwells through which upper and lower portions are perforated and being attached to a lower surface of the microfluidic chamber. The CMOS photo sensor array is disposed below the well array to capture a response image of a sample filled in microwells of the well array. The PCB has a vent formed for vacuum processing of micro flow path formed in the microfluidic chamber, a space formed between the well array and the microfluidic chamber, and a microwell formed in the well array as the liquid sample is injected through the inlet.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: August 30, 2022
    Assignee: OPTOLANE TECHNOLOGIES INC.
    Inventors: Sergiy Oleksandrov, Do Young Lee, Min Sik Song, Kyung Hak Choi
  • Patent number: 9932355
    Abstract: Provided are a pharmaceutical composition containing a 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative represented by Formula 1 as an active ingredient and a use thereof effective on a vascular inflammation-related infectious disease triggered by activity of HMGB1 protein. As investigating an anti-sepsis effect through a CLP-induced sepsis animal test that a sepsis survival rate is increased, it is identified that the pharmaceutical composition contains the 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative or a pharmaceutically available salt thereof as an active ingredient to be used as a therapeutic agent for a vascular inflammatory disease and infectious disease including sepsis triggered by activity of HMGB1 protein.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: April 3, 2018
    Assignee: KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Taeho Lee, Jong-Sup Bae, Kyung-Sik Song, Sangkyu Lee, Kwang-Hyeon Liu, Wonhwa Lee, Doohyun Lee
  • Publication number: 20150307516
    Abstract: Provided are a pharmaceutical composition containing a 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative represented by Formula 1 as an active ingredient and a use thereof effective on a vascular inflammation-related infectious disease triggered by activity of HMGB1 protein. As investigating an anti-sepsis effect through a CLP-induced sepsis animal test that a sepsis survival rate is increased, it is identified that the pharmaceutical composition contains the 2,5,6,7-tetrasubstituted thiazolo[4,5-b]pyridine derivative or a pharmaceutically available salt thereof as an active ingredient to be used as a therapeutic agent for a vascular inflammatory disease and infectious disease including sepsis triggered by activity of HMGB1 protein.
    Type: Application
    Filed: April 28, 2015
    Publication date: October 29, 2015
    Inventors: Taeho Lee, Jong-Sup Bae, Kyung-Sik Song, Sangkyu Lee, Kwang-Hyeon Liu, Wonhwa Lee, Doohyun Lee
  • Patent number: 8445038
    Abstract: Disclosed is a composition for preventing or treating cerebral infarction, cerebral edema, cerebral ischemia, or vascular dementia, for improving memory impairments, or for protecting neuronal cells, comprising as active ingredient an ethanol extract from Aralia elata, Chaenomelis Fructus, and Glycyrrhizae Radix.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: May 21, 2013
    Assignees: Chungbuk National University Industry—Academic Cooperation Foundation, Kyungpook National University Industry—Academic Cooperation Foundation
    Inventors: Yeon Hee Seong, Kyung-Sik Song, Joo Youn Kim
  • Patent number: 8211483
    Abstract: The present invention relates to a composition comprising a starch or total dietary fiber which improves the cell viability, specifically, the inventive starch and total dietary fiber isolated from the extract of Gramineae plant and the components therefrom improved the cell viability when the cells were incubated under hypoxic condition, or in the presence of beta-amyloid and 6-hydroxydopamine treatment, as well as prevented and treated myocardiac infarction, cerebral infarction and vascular dementia, or alleviated memory loss, all of which were proven using rats as the respective animal models. Therefore, they can be used as therapeutics or health care food for preventing and treating ischemic diseases or degenerative brain diseases.
    Type: Grant
    Filed: July 4, 2008
    Date of Patent: July 3, 2012
    Assignees: Hypoxi Co., Ltd., Sun Mok Institute Education Foundation
    Inventors: Jong Won Lee, Yae Sil Kim, Kyung Sik Song, Hyung Soo Han, Jung Hee Jang, Chae Ha Yang, Sun Ha Lim
  • Publication number: 20110200697
    Abstract: Disclosed is a composition for preventing or treating cerebral infarction, cerebral edema, cerebral ischemia, or vascular dementia, for improving memory impairments, or for protecting neuronal cells, comprising as active ingredient an ethanol extract from Aralia elata, Chaenomelis Fructus, and Glycyrrhizae Radix.
    Type: Application
    Filed: February 11, 2011
    Publication date: August 18, 2011
    Applicants: Chungbuk National University Industry - Academic Cooperation Foundation, Kyungpook National University Idustry - Academic Cooperation Foundation
    Inventors: Yeon Hee Seong, Kyung-Sik Song, Joo Youn Kim
  • Publication number: 20100143513
    Abstract: The present invention relates to a composition comprising a starch or total dietary fiber which improves the cell viability, specifically, the inventive starch and total dietary fiber isolated from the extract of Gramineae plant and the components therefrom improved the cell viability when the cells were incubated under hypoxic condition, or in the presence of beta-amyloid and 6-hydroxydopamine treatment, as well as prevented and treated myocardiac infarction, cerebral infarction and vascular dementia, or alleviated memory loss, all of which were proven using rats as the respective animal models. Therefore, they can be used as therapeutics or health care food for preventing and treating ischemic diseases or degenerative brain diseases.
    Type: Application
    Filed: July 4, 2008
    Publication date: June 10, 2010
    Applicants: HYPOXI CO., LTD, SUN MOK INSTITUTE EDUCATION FOUNDATION
    Inventors: Jong Won Lee, Yae Sil Kim, Kyung Sik Song, Hyung Soo Han, Jung Hee Jang, Chae Ha Yang, Sun Ha Lim